Mass spectral characterization of phloroglucinol derivatives hyperforin and adhyperforin

Rapid Communications in Mass Spectrometry

Volumn 20, Issue 18, 2006, Pages 2641-2648

  Sleno, Lekha ^a,b,d   Daneshfar, Rambod ^a   Eckert, Gunter P ^c   Müller, Walter E ^c   Volmer, Dietrich A ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEGRADATION; DISSOCIATION; MASS SPECTROMETRY; POSITIVE IONS; SPECTRUM ANALYZERS;

HYPERFORINS; HYPERICUM PERFORATUM; ION ACTIVATION; MASS SPECTRAL; PHLOROGLUCINOL; PHLOROGLUCINOL DERIVATIVES; SPECTRAL CHARACTERIZATION; ST JOHN'S WORT; TANDEM MASS SPECTROMETRY; TANDEM-MASS SPECTROMETRY;

ELECTROSPRAY IONIZATION;

EID: 33749396912     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.2650     Document Type: Article

References (29)

1. Bilia AR, Gallori S, Vincieri FF. Life Sciences 2002; 70: 3077.
2. Müller WE. Pharmacol. Res. 2003; 47: 101.
3. Melzer M, Fuhrken D, Kolkmann R. Dt. Apoth. Ztg. 1998; 138: 56.
4. Zanoli P. CNS Drug Rev. 10: 203.
5. Jensen AG, Hansen SH, Nielsen EØ. Life Sciences 2001; 68: 1593.
6. Wonnemann M, Singer A, Siebert B, Müller WE. Pharmacopsychiatry 2001; 34: S148.
7. Linde K, Mulrow CD. Cochrane Database Syst. Rev. 2000; 2: CD000448.
8. Wheatley D. Pharmacopsychiatry 1997; 30: S77.
9. Vorbach EU, Arnoldt KH, Hübner WD. Pharmacopsychiatry 1997; 30: S81.
10. Szegedi A, Kohnen R, Dienel A, Kieser M. Br. Med. J. 2005; 330: 503.
11. Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Müller WE. Life Sciences 1998; 63: 499.
12. Wonnemann M, Singer A, Müller WE. Neuropsychopharmacology 2000; 23: 188.
13. Singer A, Wonnemann M, Müller WE. J. Pharmacol. Exp. Ther. 1999; 290: 1363.
14. Müller WE, Singer A, Wonnemann M. Pharmacopsychiatry 2001; 34: S98.
15. Medina MA, Martínez-Poveda B, Amores-Sánchez MI, Quesada AR. Life Sciences 2006, published ahead of print.
16. Gartner M, Müller T, Simon JC, Giannis A, Sleeman P. ChemBioChem. 2005; 6: 171.
17. Rozio M, Fracasso C, Riva A, Morazzoni P, Caccia S. J. Chromatogr. B 2005; 816: 21.
18. Orth HCJ, Rentel C, Schmidt PC. J. Pharm. Pharmacol. 1999; 51: 193.
19. Brolis M, Gabetta B, Fuzzati N, Pace R, Panzeri F, Peterlongo F. J. Chromatogr. A 1998; 825: 9.
20. Fuzzati N, Gabetta B, Strepponi I, Villa F. J. Chromatogr. A 2001; 926: 187.
21. Mauri P, Pietta P. Rapid Commun. Mass Spectrom. 2000; 14: 95.
22. Tolonen A, Uusitalo J, Hohtola A, Jalonen J. Rapid Commun. Mass Spectrom. 2002; 16: 396.
23. Picker R, Huck CW, Bonn GK. J. Chromatogr. B 2002; 777: 147.
24. Riedel K-D, Rieger K, Martin-Facklam M, Mikus G, Haefeli WE, Burhenne J. J. Chromatogr. B 2004; 813: 27.
25. Chandrasekera DH, Welham KJ, Ashton D, Middleton R, Heinrich M. J. Pharm. Pharmacol. 2005; 57: 1645.
26. Liu F, Pan C, Drumm P, Ang CYW. J. Pharm. Biomed. Anal. 2005; 37: 303.
27. Keller J-H, Karas M, Müller WE, Volmer DA, Eckert GP, Tawab MA, Blume HH, Dingermann T, Schubert-Zsilavecz M. Anal. Chem. 2003; 75: 6084.
28. Cui Y, Ang CYW, Beger RD, Heinze TM, Hu L, Leakey J. Drug Metab. Disp. 2004; 32: 28.
29. Senko MW, Canterbury JD, Guan S, Marshall AG. Rapid Commun. Mass Spectrom. 1996; 10: 1839.